JPMorgan Healthcare Conference Delivers Buzz, Not Megadeals

TL;DR Summary
Despite high hopes for billion-dollar megadeals, the JPMorgan Healthcare Conference yielded no major announcements as rumors faded and companies staggered disclosures for other events; the shift to virtual meetings post-COVID and a thinner payer presence have shifted focus from blockbuster disclosures to networking and the biotech industry’s ongoing momentum, with eyes turning to upcoming conferences like TD Cowen in March or Jefferies later in the year for potential deals.
- All the meetings, none of the megadeals: Is JPM's purpose evolving? Fierce Biotech
- JPM 2026: Top quotes from executives Modern Healthcare
- Big Pharma enters 2026 with an appetite for deals Sherwood News
- On Day 3 of JPM, pharma threads a needle with the White House, and Novo Nordisk has an eye on M&A statnews.com
- JPM26: Dr. Oz, CMS leaders make their pitch to hospitals, payers on Trump admin healthcare policies Fierce Healthcare
Reading Insights
Total Reads
0
Unique Readers
20
Time Saved
4 min
vs 5 min read
Condensed
92%
851 → 69 words
Want the full story? Read the original article
Read on Fierce Biotech